WuXi Biologics Receives 2023 ISPE Facility of the Year Award for Operations

DUNDALK, Ireland, May 22, 2023 /PRNewswire/ — WuXi Biologics (“WuXi Bio”) (2269. HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced that the International Society for Pharmaceutical Engineering (ISPE) has awarded the company a…

Leave a Reply

Your email address will not be published. Required fields are marked *